Associated Banc-Corp’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Sell
50,359
-2,171
-4% -$167K 0.1% 129
2025
Q4
$4.17M Buy
52,530
+1,016
+2% +$80.1K 0.11% 126
2025
Q3
$3.88M Sell
51,514
-4,349
-8% -$298K 0.1% 134
2025
Q2
$3.85M Sell
55,863
-4,402
-7% -$289K 0.11% 135
2025
Q1
$4.08M Sell
60,265
-23,093
-28% -$1.38M 0.12% 127
2024
Q4
$3.74M Sell
83,358
-56,813
-41% -$3.19M 0.11% 131
2024
Q3
$8.81M Buy
140,171
+250
+0.2% +$14.6K 0.26% 87
2024
Q2
$8.26M Sell
139,921
-8,758
-6% -$548K 0.26% 86
2024
Q1
$11.9M Sell
148,679
-4,221
-3% -$322K 0.38% 72
2023
Q4
$12.1M Sell
152,900
-2,862
-2% -$204K 0.42% 69
2023
Q3
$10.9M Buy
155,762
+2,374
+2% +$168K 0.42% 68
2023
Q2
$10.6M Sell
153,388
-3,049
-2% -$217K 0.4% 75
2023
Q1
$11.6M Buy
156,437
+2,330
+2% +$195K 0.47% 68
2022
Q4
$14.4M Buy
154,107
+1,192
+0.8% +$115K 0.6% 56
2022
Q3
$14.6M Sell
152,915
-3,497
-2% -$346K 0.67% 48
2022
Q2
$14.5M Sell
156,412
-1,136
-0.7% -$111K 0.63% 52
2022
Q1
$15.9M Sell
157,548
-1,341
-0.8% -$141K 0.61% 54
2021
Q4
$16.4M Sell
158,889
-2,526
-2% -$233K 0.6% 56
2021
Q3
$13.7M Sell
161,415
-7,497
-4% -$628K 0.54% 59
2021
Q2
$14.1M Sell
168,912
-133,142
-44% -$10.9M 0.56% 57
2021
Q1
$17.9M Buy
302,054
+88,168
+41% +$6.42M 1.11% 25
2020
Q4
$14.6M Sell
213,886
-595
-0.3% -$38.7K 0.57% 53
2020
Q3
$12.5M Sell
214,481
-132,071
-38% -$8.22M 0.54% 53
2020
Q2
$22.5M Sell
346,552
-13,889
-4% -$875K 1.02% 27
2020
Q1
$21.4M Buy
360,441
+65,751
+22% +$4.39M 1.14% 22
2019
Q4
$21.9M Buy
294,690
+2,760
+0.9% +$194K 1.09% 31
2019
Q3
$18.4M Buy
291,930
+6,929
+2% +$411K 0.99% 32
2019
Q2
$15.5M Buy
285,001
+20,435
+8% +$1.1M 0.85% 37
2019
Q1
$14.3M Buy
264,566
+54,356
+26% +$3.35M 0.82% 36
2018
Q4
$13.8M Buy
210,210
+101,262
+93% +$7.56M 0.9% 32
2018
Q3
$8.58M Buy
108,948
+8,384
+8% +$599K 0.48% 68
2018
Q2
$6.47M Sell
100,564
-2,107
-2% -$139K 0.38% 75
2018
Q1
$6.39M Sell
102,671
-5,115
-5% -$367K 0.36% 75
2017
Q4
$7.82M Sell
107,786
-5,119
-5% -$372K 0.42% 66
2017
Q3
$9.18M Buy
112,905
+4,983
+5% +$394K 0.51% 62
2017
Q2
$8.68M Sell
107,922
-11,342
-10% -$896K 0.49% 61
2017
Q1
$9.36M Sell
119,264
-1,588
-1% -$127K 0.56% 56
2016
Q4
$9.54M Buy
120,852
+1,447
+1% +$117K 0.6% 52
2016
Q3
$10.6M Sell
119,405
-361
-0.3% -$34.1K 0.68% 47
2016
Q2
$11.5M Sell
119,766
-1,927
-2% -$192K 0.74% 42
2016
Q1
$12.6M Sell
121,693
-3,391
-3% -$330K 0.83% 35
2015
Q4
$12.2M Buy
125,084
+315
+0.3% +$30.9K 0.81% 39
2015
Q3
$12M Buy
124,769
+137
+0.1% +$14.4K 0.84% 36
2015
Q2
$13.1M Sell
124,632
-3,930
-3% -$402K 0.84% 35
2015
Q1
$13.3M Sell
128,562
-3,091
-2% -$313K 0.84% 37
2014
Q4
$12.7M Buy
131,653
+1,629
+1% +$144K 0.8% 43
2014
Q3
$10.3M Buy
130,024
+1,455
+1% +$115K 0.68% 47
2014
Q2
$9.69M Sell
128,569
-9,146
-7% -$691K 0.63% 50
2014
Q1
$10.3M Buy
137,715
+30,408
+28% +$2.15M 0.71% 45
2013
Q4
$7.68M Buy
107,307
+17,790
+20% +$1.14M 0.55% 57
2013
Q3
$5.08M Buy
89,517
+1,301
+1% +$77.5K 0.4% 74
2013
Q2
$5.04M Buy
+88,216
New +$5.11M 0.41% 70

Other funds holding CVS

Associated Banc-Corp's CVS Position: Q1 2026 in Review

Associated Banc-Corp reduced its CVS Health (CVS) stake by 4.1% in Q1 2026, selling an estimated $167K and leaving 50,359 shares worth $3.62M. The position accounts for 0.1% of the portfolio, ranked #129.

Associated Banc-Corp first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.5M in Q2 2020. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Associated Banc-Corp held 50,359 shares of CVS Health worth $3.62M as of Q1 2026.
  • Associated Banc-Corp sold 2,171 CVS Health shares in Q1 2026, an estimated $167K.
  • CVS Health made up 0.1% of Associated Banc-Corp's portfolio in Q1 2026, its #129 holding.
  • Associated Banc-Corp first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Associated Banc-Corp's CVS Health position peaked at $22.5M in Q2 2020.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.